Reata Pharmaceuticals Inc

GOLDMAN SACHS GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

5/14/2024

Shares

218,143

Value ($000)

22,242

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	5/14/2024	22,242	0.0%	218,143	6/30/2023
2023 Q1	5/14/2024	12,983	0.0%	142,799	3/31/2023
2022 Q4	5/14/2024	10,380	0.0%	273,218	12/31/2022
2022 Q3	5/14/2024	8,738	0.0%	347,730	9/30/2022
2022 Q2	5/14/2024	2,317	0.0%	76,255	6/30/2022
2022 Q1	5/16/2022	3,517	0.0%	107,357	3/31/2022
2021 Q4	2/17/2022	31,184	0.0%	1,182,570	12/31/2021
2021 Q3	1/20/2022	17,849	0.0%	177,409	9/30/2021
2021 Q2	8/13/2021	8,759	0.0%	61,884	6/30/2021
2021 Q1	5/17/2021	23,106	0.0%	231,751	3/31/2021
2020 Q4	2/12/2021	28,831	0.0%	233,224	12/31/2020
2020 Q3	11/13/2020	30,162	0.0%	309,610	9/30/2020
2020 Q2	8/12/2020	43,761	0.0%	280,489	6/30/2020
2020 Q1	5/15/2020	24,891	0.0%	172,442	3/31/2020
2019 Q4	2/14/2020	33,121	0.0%	162,018	12/31/2019